Chromosome 8q23.3 and 11q23.1 Variants Modify Colorectal Cancer Risk in Lynch Syndrome
Background & Aims
Recent genome-wide association studies have identified common low-risk variants for colorectal cancer (CRC). To assess whether these influence CRC risk in the Lynch syndrome, we genotyped these variants in a large series of proven mutation carriers.
Methods
We studied 675 individuals from 127 different families from the Dutch Lynch syndrome Registry whose mutation carrier status was known. We genotyped 8q24.21, 8q23.3, 10p14, 11q23.1, 15q13.3, and 18q21.1 variants in carriers of a mismatch repair gene mutation. Univariate and multivariate analysis was used to analyse the association between the presence of a risk variant and CRC risk.
Results
A significant association was found between CRC risk and rs16892766 (8q23.3) and rs3802842 (11q23.1). For rs16892766, possession of the C-allele was associated with an elevated risk of CRC in a dose-dependent fashion, with homozygosity for CC being associated with a 2.16-fold increased risk. For rs3802842, the increased risk of CRC associated with the C-allele was only found among female carriers, while CRC risk was substantially higher among homozygous (hazard ratio [HR] 3.08) than among heterozygous carriers of the C-allele (HR 1.49). In an additive model of both variants, the risk was significantly associated with the number of risk alleles (HR 1.60 for carriers of 2 or more risk alleles). The effects were stronger in female carriers than in male carriers.
Conclusion
We have identified 2 loci that are significantly associated with CRC risk in Lynch syndrome families. These modifiers may be helpful in identifying high-risk individuals who require more intensive surveillance.
Abbreviations used in this paper: CI, confidence interval, CRC, colorectal cancer, HNPCC, hereditary nonpolyposis colorectal cancer, HR, hazard ratio, HWE, Hardy–Weinberg equilibrium, kb, kilobase, LS, Lynch syndrome, MMR, mismatch repair, PCR, polymerase chain reaction
To access this article, please choose from the options below
The authors disclose the following: The study was partly funded with a Dutch Cancer Society Grant UL2005-3247 to T.W., J.T.W., and H.M.
Contributors: J.T.W., R.M.B., I.P.T., R.S.H., T.W., P.D., H.M., and H.F.V. conceived the idea for the relevant analyses and drafted the manuscript. R.E., S.J.C., A.M., and M.P. were responsible for the SNP analyses. R.M.B. and D.G. performed the statistical analyses. C.M.T., M.G.A., E.G.G., F.J.H., N.H., F.H.M., T.A.O., R.H.S., S.V., A.W., F.M.N., and J.H.K. provided clinical data and patient material. All authors critically reviewed the report and approved the final version.
PII: S0016-5085(08)01701-0
doi:10.1053/j.gastro.2008.09.033
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.

